These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nevada
|
N/A
|
|
|
(State or other jurisdiction
|
(I.R.S. Employer
|
|
|
of incorporation or organization)
|
Identification No.
|
|
|
3250 Oakland Hills Court, Fairfield, CA
|
94534
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer [ ]
|
Accelerated filer [ ]
|
|
Non-accelerated filer [ ]
|
Smaller reporting company [
X
]
|
|
(Do not check if a smaller reporting company)
|
|
PART I - FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements
|
1
|
|
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
|
8
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
13
|
|
Item 4. Controls and Procedures
|
13
|
|
PART II - OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
14
|
|
Item 1A. Risk Factors
|
15
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
17
|
|
Item 3. Defaults Upon Senior Securities
|
17
|
|
Item 4. Mine Safety Disclosures
|
18
|
|
Item 5. Other Information
|
18
|
|
Item 6. Exhibits
|
18
|
|
SIGNATURES
|
19
|
|
September 30,
|
December 31,
|
|||||||
|
2016
|
2015
|
|||||||
|
Assets
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
8,770
|
$
|
13,870
|
||||
|
Total Current Assets
|
8,770
|
13,870
|
||||||
|
Total Assets
|
$
|
8,770
|
$
|
13,870
|
||||
|
Liabilities and Stockholders’ Deficit
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
$
|
2,770
|
$
|
4,150
|
||||
|
Demand note payable
|
20,000
|
-
|
||||||
|
Total Current Liabilities
|
22,770
|
4,150
|
||||||
|
Non-Current Liabilities
|
||||||||
|
Convertible note Payable
|
87,793
|
77,757
|
||||||
|
Total Liabilities
|
110,563
|
81,907
|
||||||
|
|
|
|||||||
|
Stockholders’ Deficit
|
||||||||
|
Common stock, $0.001 par value, 75,000,000 shares authorized;
|
||||||||
|
6,000,000 shares issued and outstanding:
|
6,000
|
6,000
|
||||||
|
Additional paid-in-capital
|
63,717
|
63,717
|
||||||
|
Retained deficit
|
(171,510
|
)
|
(137,754
|
)
|
||||
|
Total Stockholders’ Deficit
|
(101,793
|
)
|
(68,037
|
)
|
||||
|
Total Liabilities and Stockholders’ Deficit
|
$
|
8,770
|
$
|
13,870
|
||||
|
Three Months
Ended
September 30,
2016
|
Three Months
Ended
September 30,
2015
|
Nine Months
Ended
September 30,
2016,
|
Nine Months
Ended
September 30,
2015
|
|||||||||||||
|
Revenue
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
General and administrative expenses
|
||||||||||||||||
|
Bank charges and interest
|
3,447 | 2,077 | 10,036 | 4,318 | ||||||||||||
|
Consulting fees
|
2,750 | 284 | 8,200 | 1,862 | ||||||||||||
|
Professional fees
|
5,409 | 9,404 | 11,282 | 23,062 | ||||||||||||
|
Filing and transfer fees
|
770 | 4,984 | 4,238 | 7,856 | ||||||||||||
|
Total general and administrative expenses
|
12,376 | 16,749 | 33,756 | 37,098 | ||||||||||||
|
Net loss from operations
|
(12,376 | ) | (16,749 | ) | (33,756 | (37,099 | ) | |||||||||
|
Provision for taxes
|
- | - | - | - | ||||||||||||
|
Net loss
|
$ | (12,376 | ) | $ | (16,749 | ) | $ | (33,756 | ) | $ | (37,098 | ) | ||||
|
Loss per common share – Basic and diluted
|
$ | (0.01 | )* | $ | (0.01 | )* | $ | (0.00 | )* | $ | (0.00 | )* | ||||
|
Weighted average number of common shares
|
||||||||||||||||
|
outstanding, basic and diluted
|
6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | ||||||||||||
|
Nine Months
Ended
September 30,
2016
|
Nine Months
Ended
September 30,
2015
|
|||||||
|
Cash derived from (used for) Operating activities
|
||||||||
|
Net loss for the period
|
$
|
(33,756
|
)
|
$
|
(37,098
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
|
||||||||
|
Changes in operating assets and liabilities
|
||||||||
|
Accrued interest included in convertible notes payable
|
10,036
|
1,107
|
||||||
|
Accounts payable and accrued expenses
|
(1,380
|
)
|
1,706
|
|||||
|
Net cash (used in) operating activities
|
(25,100
|
)
|
(34,285
|
)
|
||||
|
Investing activities
|
-
|
-
|
||||||
|
Net cash provided by (used in) investing activities
|
-
|
-
|
||||||
|
Financing activities
|
||||||||
|
Proceeds from demand loan payable
|
20,000
|
-
|
||||||
|
Proceeds from convertible note payable
|
-
|
73,825
|
||||||
|
Proceeds from loan payable
|
|
-
|
|
|
(10,614
|
)
|
||
|
Net cash provided by financing activities
|
20,000
|
63,211
|
||||||
|
Net changes in cash and equivalents
|
(5,100
|
)
|
28,926
|
|||||
|
Cash and equivalents at beginning of the year
|
13,870
|
4,663
|
||||||
|
Cash and equivalents at end of the year
|
$
|
8,770
|
$
|
33,589
|
||||
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
||||||||
|
Cash paid in interest
|
$
|
-
|
$
|
-
|
||||
|
Cash paid for income taxes
|
$
|
-
|
$
|
-
|
||||
|
·
|
our current lack of working capital;
|
|
·
|
a possible inability to raise additional financing;
|
|
·
|
the fact that our accounting policies and methods are fundamental to how we report our financial condition and results of operations, and they may require our management to make estimates about matters that are inherently uncertain;
|
|
·
|
deterioration in general or regional economic conditions;
|
|
·
|
adverse state or federal legislation or regulations that increase the costs of compliance;
|
|
·
|
inability to efficiently manage our operations; and
|
|
·
|
the unavailability of funds for capital expenditures.
|
|
As at
September 30,
2016
|
As at
December 31,
2015
|
|||||||
|
(unaudited)
|
||||||||
|
Current assets
|
$ | 8,770 | $ | 13,870 | ||||
|
Current liabilities
|
$ | 22,770 | $ | 4,150 | ||||
|
Working capital (deficit)
|
$ | (14,000 | ) | $ | 9,720 | |||
|
Nine Months
|
Nine Months
|
|||||||
|
ended
|
ended
|
|||||||
|
September 30,
|
September 30,
|
|||||||
|
2016
|
2015
|
|||||||
|
Net cash used in operating activities
|
$ | (25,100 | ) | $ | (34,285 | ) | ||
|
Net cash used in investing activities
|
- | - | ||||||
|
Net cash provided by financing activities
|
20,000 | 63,211 | ||||||
|
Net increase (decrease) in cash and cash equivalents
|
$ | (5,100 | ) | $ | 28,926 | |||
|
Operating expenditures
|
||||
|
Evaluation of new business opportunities
|
$ | 10,000 to $20,000 | ||
|
General and administrative
(including professional fees)
|
$ | 20,000 to $30,000 | ||
|
Total
|
$ | 30,000 to $50,000 | ||
|
Exhibit
Number
|
Description
|
|
|
(3)
|
Articles of Incorporation and Bylaws
|
|
|
3.1
(1)
|
Articles of Incorporation
|
|
|
3.2
(2)
|
Bylaws
|
|
|
(10)
|
Material Contracts
|
|
|
10.1
(1)
|
Form of Subscription Agreement
|
|
|
10.2
(2)
|
Transfer Agreement
|
|
|
(31)
|
Rule 13a-14 Certifications
|
|
|
31.1*
|
Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
(32)
|
Section 1350 Certifications
|
|
|
32.1*
|
Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
(101)
|
Interactive Data File
|
|
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
(1)
|
Filed as an exhibit to our registration statement on Form S-1 on March 30, 2011 and incorporated herein by reference.
|
|
(2)
|
Filed as an exhibit to our current report on Form 8-K on September 2, 2014 and incorporated herein by reference.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|